HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keisuke Kitakaze Selected Research

Enzyme Replacement Therapy

1/2016Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.
6/2011Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keisuke Kitakaze Research Topics

Disease

3GM2 Gangliosidoses (GM2 Gangliosidosis)
09/2016 - 06/2011
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
09/2016 - 01/2016
2Tay-Sachs Disease
06/2011 - 01/2011
2Sandhoff Disease (Sandhoff's Disease)
06/2011 - 01/2011
1Atopic Dermatitis (Atopic Eczema)
03/2024
1Inflammation (Inflammations)
03/2024
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Body Weight (Weight, Body)
12/2021
1Neoplasms (Cancer)
01/2021
1Fibrosis (Cirrhosis)
01/2020

Drug/Important Bio-Agent (IBA)

3Hexosaminidase BIBA
09/2016 - 06/2011
3Hexosaminidase A (Hex A)IBA
01/2016 - 01/2011
2Hexosaminidases (Hexosaminidase)IBA
09/2016 - 06/2011
1HaptensIBA
03/2024
1Immunoglobulin E (IgE)IBA
03/2024
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1sephin1IBA
12/2021
1lysophosphatidic acidIBA
01/2021
1LipidsIBA
01/2021
1Growth Differentiation Factor 15IBA
01/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2020
1G(M2) Activator ProteinIBA
09/2016
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2016
1Mannose (D-Mannose)IBA
01/2016
1Peptide Hydrolases (Proteases)FDA Link
01/2016
1lysoganglioside G(M2)IBA
01/2011
1GangliosidesIBA
01/2011
1Biomarkers (Surrogate Marker)IBA
01/2011

Therapy/Procedure

2Therapeutics
09/2016 - 01/2016
2Enzyme Replacement Therapy
01/2016 - 06/2011